Reproxalap Ophthalmic Solution Reduces Ocular Itching in Allergic Conjunctivitis Trial
The phase 3 INVIGORATE-2 trial included 131 allergic conjunctivitis patients 18 years of age and older.
Diagnosis & Disease Information
Lastacaft Eye Drops Now Available Over-the-Counter
In December 2021, the FDA approved the prescription to OTC switch for Lastacaft.
FDA Approves Disposable Contacts With Antihistamine for Allergic Conjunctivitis
Acuvue Theravision with Ketotifen reduced ocular itching within 3 minutes and the response was sustained for up to 12 hours after lens insertion.
Verkazia Approved for Vernal Keratoconjunctivitis
The approval was based on data from two randomized, multicenter, double-masked, vehicle-controlled trials that evaluated the efficacy and safety of Verkazia in patients with VKC.
- Loading...
Loading...
Next post in News
Loading... 
Loading...